Shih-Hsiang Chen

15PUBLICATIONS
25CO-AUTHORS
Medical infection agents (incl. prions)Infant and child healthHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Plant pathology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 18, 2026
Prognostic Impact of Sequential Measurable Residual Disease and KIT Variant Status in Pediatric Core-Binding Factor Acute Myeloid Leukemia: A Retrospective Multicenter Study of the Taiwan Pediatric Oncology Group.

|Mar 26, 2025
Clinical Value of Tocilizumab in Reducing Mortality in Refractory Septic Shock in Children with Hematologic and Non-Hematologic Diseases.

En-Pei Lee, Jainn-Jim Lin, Shih-Hsiang Chen

|Mar 25, 2025
Frequency and prognostic value of unconventional genetic subtypes in paediatric and young adult B-cell precursor acute lymphoblastic leukaemia in Taiwan.

Ying-Jung Huang, Hsi-Che Liu, Ming-Chung Kuo

|Jun 26, 2024
Blinatumomab in Children with MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 11 Cases.

Yi-Lun Wang, Tsung-Yen Chang, Yu-Chuan Wen

|Apr 27, 2024
Outcome of Tocilizumab Treatment in Febrile Neutropenic Children with Severe Sepsis/Septic Shock in a Single-Center Retrospective Case Series.

Shih-Hsiang Chen, Tsung-Yen Chang, Yi-Lun Wang

|Mar 13, 2024
Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: Combining IKZF1plus and Day 15 MRD positivity.

Hsi-Che Liu, Ying-Jung Huang, Tang-Her Jaing

Pageof 3

Frequent Collaborators

9 joint publications

Tang-Her Jaing

6 joint publications

Lee-Yung Shih

6 joint publications

Ting-Chi Yeh

4 joint publications

Hsi-Che Liu